Showing results (31-40 of 114) with videos related to
Sort By:
Pageof 12
Blood|March 23, 2011
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765Sarah E M Herman, Amber L Gordon, Erin Hertlein, et al.Child Psychiatry and Human Development|January 12, 2018
Homelessness, Mental Health and Suicidality Among LGBTQ Youth Accessing Crisis ServicesHarmony Rhoades, Joshua A Rusow, David Bond, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 2, 2019
Ibrutinib for Chronic Graft-versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 StudyEdmund K Waller, David Miklos, Corey Cutler, et al.Journal of Geriatric Oncology|July 10, 2018
Use of a comprehensive frailty assessment to predict morbidity in patients with multiple myeloma undergoing transplantAshley E Rosko, Ying Huang, Don M Benson, et al.Leukemia & Lymphoma|June 12, 2024
Impact of chronic graft-<i>versus</i>-host disease on non-relapse mortality and survivalJustin Jiang, Audrey M Sigmund, Qiuhong Zhao, et al.Leukemia & Lymphoma|November 24, 2020
Comparison of fixed dose reduced-intensity conditioning with fludarabine and busulfan to PK-guided busulfan AUC (FluBu4K) in hematopoietic stem cell transplant for AML/MDSBrendan Rasor, Tyler Dickerson, Qiuhong Zhao, et al.Endocrinology|November 26, 2014
Toll-like receptor 3 is critical for coxsackievirus B4-induced type 1 diabetes in female NOD miceKelly D McCall, Jean R Thuma, Maria C Courreges, et al.Journal of Hematology & Oncology|June 14, 2017
Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphomaNarendranath Epperla, Kwang Woo Ahn, Sairah Ahmed, et al.Transplantation and Cellular Therapy|July 28, 2022
Secondary Impact of the Coronavirus Disease 19 Pandemic on Patients and the Cellular Therapy Healthcare EcosystemJane Koo, Jeffrey J Auletta, David M Hartley, et al.Leukemia & Lymphoma|July 4, 2015
Tocilizumab for steroid refractory acute graft-versus-host diseaseJulianna V F Roddy, Bradley M Haverkos, Ali McBride, et al.Pageof 12